- Markets
- Chemicals
- 3BBLACKBIO
3BBLACKBIO
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
3B Blackbio DX Gets Tax Order For Demand Of 44.6 Million Rupees
Jan 3 (Reuters) - 3B Blackbio DX Ltd 3BBL.BO:
3B BLACKBIO DX - GOT TAX ORDER FOR DEMAND OF 44.6 MILLION RUPEES
Source text: ID:nBSE2zRtzQ
Further company coverage: 3BBL.BO
(([email protected];))
Jan 3 (Reuters) - 3B Blackbio DX Ltd 3BBL.BO:
3B BLACKBIO DX - GOT TAX ORDER FOR DEMAND OF 44.6 MILLION RUPEES
Source text: ID:nBSE2zRtzQ
Further company coverage: 3BBL.BO
(([email protected];))
3B Blackbio DX Gets Order Worth 13.7 Million Rupees
Sept 17 (Reuters) - 3B Blackbio DX Ltd 3BBL.BO:
3B BLACKBIO DX LTD - RECEIVED AN ORDER WORTH 13.7 MILLION RUPEES
Source text for Eikon: ID:nBSE7r4ndC
Further company coverage: 3BBL.BO
(([email protected];;))
Sept 17 (Reuters) - 3B Blackbio DX Ltd 3BBL.BO:
3B BLACKBIO DX LTD - RECEIVED AN ORDER WORTH 13.7 MILLION RUPEES
Source text for Eikon: ID:nBSE7r4ndC
Further company coverage: 3BBL.BO
(([email protected];;))
3B Blackbio Dx Gets Export Order Worth $192,800
Jan 10 (Reuters) - 3B Blackbio DX Ltd 3BBL.BO:
GETS EXPORT ORDER WORTH $192,800
Further company coverage: 3BBL.BO
(([email protected];))
Jan 10 (Reuters) - 3B Blackbio DX Ltd 3BBL.BO:
GETS EXPORT ORDER WORTH $192,800
Further company coverage: 3BBL.BO
(([email protected];))
Kilpest India Says National Company Law Tribunal Approved Scheme Of Amalgamation Between 3B Blackbio Biotech India, Kilpest India
Aug 8 (Reuters) - Kilpest India Ltd KILP.BO:
NATIONAL COMPANY LAW TRIBUNAL APPROVED SCHEME OF AMALGAMATION BETWEEN 3B BLACKBIO BIOTECH INDIA KILPEST INDIA
Source text for Eikon: ID:nBSE5dwMgM
Further company coverage: KILP.BO
(([email protected];;))
Aug 8 (Reuters) - Kilpest India Ltd KILP.BO:
NATIONAL COMPANY LAW TRIBUNAL APPROVED SCHEME OF AMALGAMATION BETWEEN 3B BLACKBIO BIOTECH INDIA KILPEST INDIA
Source text for Eikon: ID:nBSE5dwMgM
Further company coverage: KILP.BO
(([email protected];;))
Kilpest India Final Dividend 2.5 Rupees Per Share
May 29 (Reuters) - Kilpest India Ltd KILP.BO:
KILPEST INDIA LTD - FINAL DIVIDEND 2.5 RUPEES PER SHARE
Source text for Eikon: ID:nBSE84l8Df
Further company coverage: KILP.BO
(([email protected];))
May 29 (Reuters) - Kilpest India Ltd KILP.BO:
KILPEST INDIA LTD - FINAL DIVIDEND 2.5 RUPEES PER SHARE
Source text for Eikon: ID:nBSE84l8Df
Further company coverage: KILP.BO
(([email protected];))
Events:
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
More Small Cap Ideas
See similar 'Small' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does 3B Blackbio Dx do?
Established in 1972, KILPEST is a leading Agri-based company in India. Initially the only pesticide formulating company in Madhya Pradesh, it has grown to manufacture 50 pesticide products, microfertilizers, biofertilizers, and biopesticides in Central India.
Who are the competitors of 3B Blackbio Dx?
3B Blackbio Dx major competitors are TTK Healthcare, Nureca Ltd., QMS Medi Allied Ser., Poly Medicure, Amrutanjan Healthcar, Cupid, Max India. Market Cap of 3B Blackbio Dx is ₹1,541 Crs. While the median market cap of its peers are ₹1,776 Crs.
Is 3B Blackbio Dx financially stable compared to its competitors?
3B Blackbio Dx seems to be financially stable compared to its competitors. The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
Does 3B Blackbio Dx pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. 3B Blackbio Dx latest dividend payout ratio is 8.01% and 3yr average dividend payout ratio is 13.56%
How has 3B Blackbio Dx allocated its funds?
Companies resources are majorly tied in miscellaneous assets
How strong is 3B Blackbio Dx balance sheet?
Balance sheet of 3B Blackbio Dx is strong. It shouldn't have solvency or liquidity issues.
Is the profitablity of 3B Blackbio Dx improving?
Yes, profit is increasing. The profit of 3B Blackbio Dx is ₹48.45 Crs for TTM, ₹32.1 Crs for Mar 2024 and ₹25.94 Crs for Mar 2023.
Is the debt of 3B Blackbio Dx increasing or decreasing?
Yes, The debt of 3B Blackbio Dx is increasing. Latest debt of 3B Blackbio Dx is -₹65.9 Crs as of Sep-24. This is greater than Mar-24 when it was -₹123.37 Crs.
Is 3B Blackbio Dx stock expensive?
Yes, 3B Blackbio Dx is expensive. Latest PE of 3B Blackbio Dx is 32.07, while 3 year average PE is 15.81. Also latest EV/EBITDA of 3B Blackbio Dx is 28.33 while 3yr average is 13.07.
Has the share price of 3B Blackbio Dx grown faster than its competition?
3B Blackbio Dx has given better returns compared to its competitors. 3B Blackbio Dx has grown at ~103.09% over the last 2yrs while peers have grown at a median rate of 5.72%
Is the promoter bullish about 3B Blackbio Dx?
Promoters seem not to be bullish about the company and have been selling shares in the open market. Latest quarter promoter holding in 3B Blackbio Dx is 41.28% and last quarter promoter holding is 41.29%
Are mutual funds buying/selling 3B Blackbio Dx?
There is Insufficient data to gauge this.